Immigrants to the U.S. contributed $115.2 billion more to the Medicare Trust Fund during the past decade than they withdrew, casting doubt on criticism they overburden the health plan, Harvard University researchers said.
Catherine DeAngelis, the first female editor-in-chief of the Journal of the American Medical Association , is stepping down after a decade of raising the standards for fact checking of the pharmaceutical industry.
Drug companies and medical-device makers would be forced to publicly disclose any money paid to doctors under new U.S. regulations designed to make patients aware of conflicts of interest that may affect their health.
Europe’s drug regulator will make thousands of pages of clinical trial reports public next week after pressure from drug-safety activists because of suicide risks linked to Sanofi-Aventis SA ’s failed diet pill Acomplia.
The Food and Drug Administration is weighing whether to let consumers buy medicines for some chronic conditions without a prescription while speeding approvals of drugs for infection, Alzheimer’s disease and rare conditions.
U.S. regulators won’t re-examine safety data from fen-phen, the recalled diet drug tied to heart damage, as they review a new generation of weight-loss pills led by Vivus Inc. ’s Qnexa that use some of the same ingredients.
The American Red Cross, the biggest U.S. supplier of donated blood, failed to correct violations of blood-safety rules, raising the risk that ill-suited blood will be used in transfusions, U.S. regulators said.